{"title":"Validation of the Arabic Version of Asthma Numeracy Questionnaire (ANQ) Among Parents of Asthmatic Children: Factor and Rasch Analyses Study.","authors":"Walid Al-Qerem, Anan Jarab, Abdel Qader Al Bawab, Judith Eberhardt, Fawaz Alasmari, Alaa Hammad, Enas Al-Zayadneh, Montaha Al-Iede, Lujain Al-Sa'di, Raghd Obidat","doi":"10.2147/JAA.S486682","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The increasing global prevalence of asthma necessitates effective disease management, with patients and their families playing a central role. Enhancing health literacy (HL) among caregivers is critical to improving asthma outcomes.</p><p><strong>Purpose: </strong>This study aimed to validate the Arabic version of the Asthma Numeracy Questionnaire (Ar-ANQ) to address the gap in HL assessment tools for Arabic-speaking populations.</p><p><strong>Patients and methods: </strong>A total of 400 parents of children with asthma completed the Ar-ANQ at an outpatient respiratory clinic. Confirmatory factor analysis (CFA) and Rasch analysis were employed to evaluate the psychometric properties of the instrument.</p><p><strong>Results: </strong>CFA supported the unidimensional structure of the Ar-ANQ, with excellent model fit indices (χ²/df = 4.6, SRMR = 0.02, CFI = 0.99, GFI = 0.99, TLI = 0.96) and high internal consistency (Cronbach's α = 0.82). Rasch analysis further demonstrated psychometric robustness, with high person and item separation reliabilities (0.74 and 0.99, respectively) and acceptable infit and outfit statistics.</p><p><strong>Conclusion: </strong>The Arabic version of the Asthma Numeracy Questionnaire (Ar-ANQ) is a reliable and valid instrument for assessing health literacy among parents of children with asthma.</p>","PeriodicalId":15079,"journal":{"name":"Journal of Asthma and Allergy","volume":"18 ","pages":"13-25"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11724629/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Asthma and Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JAA.S486682","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The increasing global prevalence of asthma necessitates effective disease management, with patients and their families playing a central role. Enhancing health literacy (HL) among caregivers is critical to improving asthma outcomes.
Purpose: This study aimed to validate the Arabic version of the Asthma Numeracy Questionnaire (Ar-ANQ) to address the gap in HL assessment tools for Arabic-speaking populations.
Patients and methods: A total of 400 parents of children with asthma completed the Ar-ANQ at an outpatient respiratory clinic. Confirmatory factor analysis (CFA) and Rasch analysis were employed to evaluate the psychometric properties of the instrument.
Results: CFA supported the unidimensional structure of the Ar-ANQ, with excellent model fit indices (χ²/df = 4.6, SRMR = 0.02, CFI = 0.99, GFI = 0.99, TLI = 0.96) and high internal consistency (Cronbach's α = 0.82). Rasch analysis further demonstrated psychometric robustness, with high person and item separation reliabilities (0.74 and 0.99, respectively) and acceptable infit and outfit statistics.
Conclusion: The Arabic version of the Asthma Numeracy Questionnaire (Ar-ANQ) is a reliable and valid instrument for assessing health literacy among parents of children with asthma.
期刊介绍:
An international, peer-reviewed journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physiology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.
Although the main focus of the journal will be to publish research and clinical results in humans, preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies.